CONCORD BIOTECH
Smallcap | BSE
Sector
Index
Here's the live share price of Concord Biotech along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.49₹ 6.60
As on Jun 12, 2026, 04:01 PM IST
Source: Dion Global
Concord Biotech Price Performance
Today's LowToday's High
₹1,337.60₹1,366.80
₹1,351.90
52 Weeks' Low52 Weeks' High
₹987.05₹2,143.95
₹1,351.90
Open Price
₹1,343.50
Prev. Close
₹1,345.30
Volume
37,363
Source: Dion Global
Concord Biotech Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Concord Biotech | 11.67 | 19.91 | 15.14 | -1.36 | -34.38 | 12.80 | 7.50 |
| Sun Pharmaceutical Industries | 1.33 | -2.09 | -0.97 | 0.72 | 7.13 | 22.41 | 21.69 |
| Divi's Laboratories | 0.08 | -0.22 | 5.61 | 3.14 | -1.40 | 24.47 | 8.61 |
| Torrent Pharmaceuticals | 3.58 | 4.50 | 2.98 | 20.79 | 40.38 | 36.26 | 25.17 |
| Cipla | -0.85 | 7.49 | 4.80 | -8.46 | -7.54 | 13.10 | 7.31 |
| Zydus Lifesciences | 1.42 | 18.65 | 20.49 | 18.87 | 12.85 | 29.38 | 11.01 |
| Dr. Reddy's Laboratories | -0.31 | 0.29 | -3.41 | -0.46 | -6.55 | 10.87 | 3.13 |
| Lupin | 1.05 | 2.05 | -2.75 | 8.41 | 13.34 | 40.92 | 13.96 |
| Mankind Pharma | 2.29 | 0.54 | 8.24 | 9.67 | 0.15 | 17.47 | 10.91 |
| Aurobindo Pharma | 0.46 | -1.30 | 11.88 | 23.09 | 27.21 | 30.34 | 8.12 |
| Laurus Labs | -3.70 | 9.75 | 33.24 | 37.30 | 109.16 | 59.47 | 17.52 |
| Biocon | 1.58 | 4.08 | 6.58 | 8.25 | 18.77 | 20.51 | 0.32 |
| Alkem Laboratories | 0.70 | -3.88 | -2.93 | -6.10 | 9.15 | 16.47 | 10.34 |
| Glenmark Pharmaceuticals | 0.36 | -3.65 | -3.76 | 10.09 | 32.69 | 50.42 | 27.55 |
| Abbott India | 1.20 | -2.11 | -1.37 | -5.83 | -16.35 | 6.25 | 10.09 |
| Anthem Biosciences | 3.22 | -1.72 | 22.84 | 12.50 | 7.69 | 2.50 | 1.49 |
| Ipca Laboratories | -3.17 | 5.23 | 2.02 | 8.44 | 15.02 | 29.61 | 8.72 |
| Ajanta Pharma | 5.05 | 1.20 | 0.19 | 17.58 | 14.63 | 29.64 | 19.33 |
| Gland Pharma | -0.75 | 20.46 | 36.14 | 34.26 | 35.31 | 33.11 | -6.51 |
| J B Chemicals & Pharmaceuticals | 4.09 | 5.83 | 5.94 | 25.45 | 29.40 | 28.30 | 23.91 |
Source: Dion Global
Over the last one year, Concord Biotech has declined 34.38% compared to peers like Sun Pharmaceutical Industries (7.13%), Divi's Laboratories (-1.40%), Torrent Pharmaceuticals (40.38%). From a 5 year perspective, Concord Biotech has underperformed peers relative to Sun Pharmaceutical Industries (21.69%) and Divi's Laboratories (8.61%).
Concord Biotech Financials
Source: Dion Global
Concord Biotech Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,248.87 | 1,284.26 |
| 10 | 1,182.02 | 1,236.75 |
| 20 | 1,157.9 | 1,193.6 |
| 50 | 1,112.91 | 1,159.08 |
| 100 | 1,153.7 | 1,192.34 |
| 200 | 1,329.23 | 1,307.75 |
Source: Dion Global
Concord Biotech Share Holding Pattern
In the latest quarter, Concord Biotech remained same as its previous close in promoter holding, while DII stake decreased to 9.22%, FII holding rose to 7.79%, and public shareholding moved up to 38.90% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Concord Biotech Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 13,31,725 | 0.85 | 152.08 | |
| 4,96,688 | 1.81 | 56.72 | |
| 4,62,606 | 0.89 | 52.83 | |
| 1,78,114 | 0.42 | 20.34 | |
| 1,11,738 | 0.15 | 12.76 | |
| 42,148 | 0.63 | 4.81 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Concord Biotech Corporate Actions
Date Time | Announcement |
|---|---|
| Jun 12, 2026, 07:00 PM IST IST | Concord Biotech - Completion Of ANVISA Inspection Conducted By The Brazilian Health Regulatory Agency At The Limbasi API Manu |
| Jun 10, 2026, 03:38 PM IST IST | Concord Biotech - Concord Biotech Secures Abbreviated New Drug Application (ANDA) Approval For Tofacitinib Tablets, 5 Mg And |
| Jun 06, 2026, 12:05 AM IST IST | Concord Biotech - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Jun 02, 2026, 10:05 PM IST IST | Concord Biotech - Concord Biotech Secures Abbreviated New Drug Application (ANDA) Approval For Mycophenolate Mofetil For Oral |
| Jun 01, 2026, 11:37 PM IST IST | Concord Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
Source: Dion Global
About Concord Biotech
Concord Biotech Ltd. is a Public Limited Listed company incorporated on 23/11/1984 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1984PLC007440 and registration number is 007440. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1055.07 Cr. and Equity Capital is Rs. 10.46 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- Address1482-1486, Trasad Road, Ahmedabad Gujarat 382225
- Contact
Source: Dion Global
Management
- Mr. Sudhir VaidChairman & Managing Director
- Mr. Ankur VaidJoint Managing Director & CEO
- Mr. Ravi KapoorNon Executive Director
- Mr. Rajiv Ambrish AgarwalNon Executive Director
- Mrs. Bharti KhannaIndependent Director
- Mr. Amitabh ThakoreIndependent Director
- Mr. Arvind AgarwalIndependent Director
- Mr. Jayaram EaswaranIndependent Director
- Mr. Mandayam Chakravarthy SriramanIndependent Director
FAQs on Concord Biotech Share Price
What is the share price of Concord Biotech?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Concord Biotech is ₹1,351.90 as on Jun 12, 2026.
What kind of stock is Concord Biotech?
The Concord Biotech is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Concord Biotech?
The market cap of Concord Biotech is ₹14,143.06 Cr as on Jun 12, 2026.
What are today's High and Low prices of Concord Biotech?
Today’s highest and lowest price of Concord Biotech are ₹1,366.80 and ₹1,337.60.
What are the 52 Week High and 52 Week Low of Concord Biotech?
The 52-week high/low is the highest and lowest price at which Concord Biotech stock has traded in the past 52-week or nearly a year. The 52-week high of Concord Biotech is ₹2,143.95 and 52-week low of Concord Biotech is ₹987.05 as on Jun 12, 2026.
How has the Concord Biotech performed historically in terms of returns?
The Concord Biotech has shown returns of 0.49% over the past day, 19.91% for the past month, 15.14% over 3 months, -34.38% over 1 year, 12.8% across 3 years, and 7.5% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Concord Biotech?
P/E ratio of and PB ratio of Concord Biotech are 54.21 and 7.01 on Jun 12, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
✕